Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes. 2007

Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan. hanioka@pharm.okayama-u.ac.jp

Cytochrome P450 2E1 (CYP2E1) is an enzyme of major toxicological interest because it metabolizes various drugs, precarcinogens and solvents to reactive metabolites. In this study, human and cynomolgus monkey CYP2E1 cDNAs (humCYP2E1 and monCYP2E1, respectively) were cloned, and the corresponding proteins were heterologously expressed in yeast cells to identify the functions of primate CYP2E1s. The enzymatic properties of CYP2E1 proteins were characterized by kinetic analysis of chlorzoxazone 6-hydroxylation and 4-nitrophenol 2-hydroxylation. humCYP2E1 and monCYP2E1 enzymes showed 94.3% identity in their amino acid sequences. The functional CYP content in yeast cell microsomes expressing humCYP2E1 was 38.4 pmol/mg protein. The level of monCYP2E1 was 42.7% of that of humCYP2E1, although no significant differences were statistically observed. The K(m) values of microsomes from human livers and yeast cells expressing humCYP2E1 for CYP2E1-dependent oxidation were 822 and 627 microM for chlorzoxazone 6-hydroxylation, and 422 and 514 microM for 4-nitrophenol 2-hydroxylation, respectively. The K(m) values of microsomes from cynomolgus monkey livers and yeast cells expressing monCYP2E1 were not significantly different from those of humans in any enzyme source. V(max) and V(max)/K(m) values of human liver microsomes for CYP2E1-dependent oxidation were 909 pmol/min/mg protein and 1250 nl/min/mg protein for chlorzoxazone 6-hydroxylation, and 1250 pmol/min/mg protein and 2990 nl/min/mg protein for 4-nitrophenol 2-hydroxylation, respectively. The kinetic parameter values of cynomolgus monkey livers were comparable to or lower than those of human liver microsomes (49.5-102%). In yeast cell microsomes expressing humCYP2E1, V(max) and V(max)/K(m) values for CYP2E1-dependent oxidation on the basis of CYP holoprotein level were 170 pmol/min/pmol CYP and 272 nl/min/pmol CYP for chlorzoxazone 6-hydroxylation, and 139 pmol/min/pmol CYP and 277 nl/min/pmol CYP for 4-nitrophenol 2-hydroxylation, respectively, and the kinetic parameters of monCYP2E1 exhibited similar values. These findings suggest that human and cynomolgus monkey CYP2E1 enzymes have high homology in their amino acid sequences, and that their enzymatic properties are considerably similar. The information gained in this study should help with in vivo extrapolation and to assess the toxicity of xenobiotics.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
September 2017, Biopharmaceutics & drug disposition,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
December 2006, Chemico-biological interactions,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
August 2010, Life sciences,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
June 2003, Xenobiotica; the fate of foreign compounds in biological systems,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
January 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
May 2006, Journal of biochemistry,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
January 2023, Methods in enzymology,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
January 1996, Methods in enzymology,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
December 2015, Biopharmaceutics & drug disposition,
Nobumitsu Hanioka, and Maki Yamamoto, and Hiroyuki Iwabu, and Hideto Jinno, and Toshiko Tanaka-Kagawa, and Shinsaku Naito, and Takefumi Shimizu, and Kazufumi Masuda, and Takashi Katsu, and Shizuo Narimatsu
January 1996, Chemical research in toxicology,
Copied contents to your clipboard!